Ascendis Pharma (ASND) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

Ascendis Pharma Revenue Highlights


Latest Revenue (Y)

$266.72M

Latest Revenue (Q)

$95.89M

Main Geography (Y)

North America

Ascendis Pharma Revenue by Period


Ascendis Pharma Revenue by Year

DateRevenueChange
2023-12-31$266.72M421.20%
2022-12-31$51.17M557.93%
2021-12-31$7.78M11.87%
2020-12-31$6.95M-48.01%
2019-12-31$13.38M26.41%
2018-12-31$10.58M591.57%
2017-12-31$1.53M-66.78%
2016-12-31$4.61M-43.26%
2015-12-31$8.12M-41.94%
2014-12-31$13.98M-31.48%
2013-12-31$20.41M30.96%
2012-12-31$15.58M-

Ascendis Pharma generated $266.72M in revenue during NA 2023, up 421.20% compared to the previous quarter, and up 2520.73% compared to the same period a year ago.

Ascendis Pharma Revenue by Quarter

DateRevenueChange
2024-03-31$95.89M-30.36%
2023-12-31$137.70M186.68%
2023-09-30$48.03M1.35%
2023-06-30$47.39M41.10%
2023-03-31$33.59M46.70%
2022-12-31$22.90M49.74%
2022-09-30$15.29M148.21%
2022-06-30$6.16M-9.78%
2022-03-31$6.83M39.43%
2021-12-31$4.90M339.98%
2021-09-30$1.11M8.90%
2021-06-30$1.02M37.00%
2021-03-31$746.00K39.44%
2020-12-31$535.00K-80.59%
2020-09-30$2.76M91.99%
2020-06-30$1.44M-35.46%
2020-03-31$2.23M-11.25%
2019-12-31$2.51M11.77%
2019-09-30$2.24M-30.15%
2019-06-30$3.21M-40.69%
2019-03-31$5.41M-48.51%
2018-12-31$10.52M52475.00%
2018-09-30$20.00K11.11%
2018-06-30$18.00K-35.71%
2018-03-31$28.00K-90.00%
2017-12-31$280.00K-35.48%
2017-09-30$434.00K-2.25%
2017-06-30$444.00K19.35%
2017-03-31$372.00K-64.33%
2016-12-31$1.04M-10.78%
2016-09-30$1.17M2.90%
2016-06-30$1.14M-9.70%
2016-03-31$1.26M-36.37%
2015-12-31$1.98M-6.61%
2015-09-30$2.12M8.96%
2015-06-30$1.94M-6.63%
2015-03-31$2.08M-26.36%
2014-12-31$2.83M-13.05%
2014-09-30$3.25M-16.94%
2014-06-30$3.91M-2.03%
2014-03-31$3.99M-28.15%
2013-12-31$5.56M-

Ascendis Pharma generated $95.89M in revenue during Q1 2024, up -30.36% compared to the previous quarter, and up 418.82% compared to the same period a year ago.

Ascendis Pharma Revenue Breakdown


Ascendis Pharma Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 22Dec 21Dec 20Dec 19Dec 18
CHINA$6.47M$922.00K$4.27M$10.72M-
North America$44.16M$6.86M$2.68M$2.65M-
Europe$552.00K----
Country of domicile-----

Ascendis Pharma's latest annual revenue breakdown by geography, as of Dec 22: North America (86.29%), CHINA (12.64%), and Europe (1.08%).

Quarterly Revenue by Country

CountryMar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Dec 20
North America$33.07M$19.73M$-12.89M$5.08M$6.46M$4.78M$702.00K$688.00K$722.00K
CHINA$519.00K$3.04M$2.25M$942.00K$237.00K$117.00K$411.00K$334.00K$-187.00K
Europe-$126.00K$151.00K$140.00K$135.00K----

Ascendis Pharma's latest quarterly revenue breakdown by geography, as of Mar 23: North America (98.45%), and CHINA (1.55%).

Ascendis Pharma Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
BGNEBeiGene$2.46B$929.17M
UTHRUnited Therapeutics$2.33B$748.90M
AMLXAmylyx Pharmaceuticals$380.79M$88.64M
APLSApellis Pharmaceuticals$366.28M$179.14M
ASNDAscendis Pharma$266.72M$95.89M
BPMCBlueprint Medicines$249.38M$128.18M
ACLXArcellx$110.32M$27.38M
STOKStoke Therapeutics$8.78M$4.22M
KDNYChinook Therapeutics$6.13M$1.01M
CRNXCrinetics Pharmaceuticals$4.01M$640.00K
PLRXPliant Therapeutics$1.58M-
KRTXKaruna Therapeutics$654.00K-
NUVLNuvalent--
DAWNDay One Biopharmaceuticals-$20.07M
DICEDICE Therapeutics--
REPLReplimune Group--
MDGLMadrigal Pharmaceuticals-$62.17M
VTYXVentyx Biosciences--
ETNB89bio--
AKROAkero Therapeutics--

ASND Revenue FAQ


Ascendis Pharma's yearly revenue for 2023 was $266.72M, representing an increase of 421.20% compared to 2022. The company's yearly revenue for 2022 was $51.17M, representing an increase of 557.93% compared to 2021. ASND's yearly revenue for 2021 was $7.78M, representing an increase of 11.87% compared to 2020.

Ascendis Pharma's quarterly revenue for Q1 2024 was $95.89M, a -30.36% decrease from the previous quarter (Q4 2023), and a 185.49% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $137.7M, a 186.68% increase from the previous quarter (Q3 2023), and a 501.42% increase year-over-year (Q4 2022). ASND's quarterly revenue for Q3 2023 was $48.03M, a 1.35% increase from the previous quarter (Q2 2023), and a 214.15% increase year-over-year (Q3 2022).

Ascendis Pharma's revenue growth rate for the last 3 years (2021-2023) was 3329.13%, and for the last 5 years (2019-2023) was 1894.15%.